According to filings with the U.S. Securities and Exchange Commission, BioMEMS Diagnostics is raising $3,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Casey Fowler played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About BioMEMS Diagnostics
BioMEMS Diagnostics is a contract testing service and developer/licensor of customer-specified test kits. It has developed a simple-to-use, extremely sensitive, and affordable testing platform that allows new tests to be developed in weeks, instead of years. This hand-held, portable device produces results in under 5 minutes and ports them to a paired smartphone, completely displacing the current paradigm of collecting samples, transporting to a remote lab, and waiting for results when sophisticated tests are needed. This proprietary, patented, digital testing platform is usable to test across various categories including anti-aging, metabolic or nutritional deficits, and infectious diseases. The platform is extremely disruptive, transforming both point-of-care and at home diagnostics.

To learn more about BioMEMS Diagnostics, visit http://www.biomemsdiagnostics.com/

Contact:
Casey Fowler, President and Chief Executive Officer
703-504-8604

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.